• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TLR4 调控 1 型糖尿病非肥胖型糖尿病小鼠模型中心脏脂质蓄积和糖尿病性心脏病。

TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes.

机构信息

Section of Endocrinology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut, USA.

出版信息

Am J Physiol Heart Circ Physiol. 2012 Sep 15;303(6):H732-42. doi: 10.1152/ajpheart.00948.2011. Epub 2012 Jul 27.

DOI:10.1152/ajpheart.00948.2011
PMID:22842069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3468457/
Abstract

Toll-like receptor (TLR)4 regulates inflammation and metabolism and has been linked to the pathogenesis of heart disease. TLR4 is upregulated in diabetic cardiomyocytes, and we examined the role of TLR4 in modulating cardiac fatty acid (FA) metabolism and the pathogenesis of diabetic heart disease in nonobese diabetic (NOD) mice. Both wild-type (WT) NOD and TLR4-deficient NOD animals had increased plasma triglyceride levels after the onset of diabetes. However, by comparison, TLR4-deficient NOD mouse hearts had lower triglyceride accumulation in the early stages of diabetes, which was associated with a reduction in myeloid differentiation primary response gene (88) (MyD88), phosphorylation of p38 MAPK (phospho-p38), lipoprotein lipase (LPL), and JNK levels but increased phospho-AMP-activated protein kinase (AMPK). Oleic acid treatment in H9C2 cardiomyocytes also led to cellular lipid accumulation, which was attenuated by TLR4 small interfering RNA. TLR4 deficiency in the cells decreased FA-induced augmentation of MyD88, phospho-p38, and LPL, suggesting that TLR4 may modulate FA-induced lipid metabolism in cardiomyocytes. In addition, although cardiac function was impaired in both diabetic WT NOD and TLR4-deficient NOD animals compared with control nondiabetic mice, this deficit was less in the diabetic TLR4-deficient NOD mice, which had greater ejection fraction, greater fractional shortening, and increased left ventricular developed pressure in the early stages after the development of diabetes compared with their diabetic WT NOD counterparts. Thus, we conclude that TLR4 plays a role in regulating lipid accumulation in cardiac muscle after the onset of type 1 diabetes, which may contribute to cardiac dysfunction.

摘要

Toll 样受体(TLR)4 调节炎症和代谢,与心脏病的发病机制有关。糖尿病心肌细胞中 TLR4 上调,我们研究了 TLR4 在调节心脏脂肪酸(FA)代谢和非肥胖型糖尿病(NOD)小鼠糖尿病性心脏病发病机制中的作用。WT NOD 和 TLR4 缺陷型 NOD 动物在糖尿病发病后血浆甘油三酯水平均升高。然而,相比之下,TLR4 缺陷型 NOD 小鼠心脏在糖尿病早期的甘油三酯积累较低,这与髓样分化初级反应基因(88)(MyD88)、磷酸化 p38MAPK(磷酸化 p38)、脂蛋白脂肪酶(LPL)和 JNK 水平降低,但磷酸化 AMP 激活的蛋白激酶(AMPK)增加有关。油酸处理 H9C2 心肌细胞也导致细胞脂质积累,TLR4 小干扰 RNA 可减轻这种积累。细胞中的 TLR4 缺陷降低了 FA 诱导的 MyD88、磷酸化 p38 和 LPL 的增强,表明 TLR4 可能调节心肌细胞中 FA 诱导的脂质代谢。此外,尽管与对照非糖尿病小鼠相比,糖尿病 WT NOD 和 TLR4 缺陷型 NOD 动物的心脏功能均受损,但在糖尿病 TLR4 缺陷型 NOD 小鼠中,这种缺陷较小,这些小鼠在糖尿病发病后的早期阶段具有更高的射血分数、更大的缩短分数和增加的左心室发展压。因此,我们得出结论,TLR4 在 1 型糖尿病发病后调节心脏肌肉中的脂质积累中起作用,这可能导致心脏功能障碍。

相似文献

1
TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes.TLR4 调控 1 型糖尿病非肥胖型糖尿病小鼠模型中心脏脂质蓄积和糖尿病性心脏病。
Am J Physiol Heart Circ Physiol. 2012 Sep 15;303(6):H732-42. doi: 10.1152/ajpheart.00948.2011. Epub 2012 Jul 27.
2
Farrerol Alleviates Diabetic Cardiomyopathy by Regulating AMPK-Mediated Cardiac Lipid Metabolic Pathways in Type 2 Diabetic Rats.法呢醇通过调节 2 型糖尿病大鼠 AMPK 介导的心脏脂质代谢通路减轻糖尿病心肌病。
Cell Biochem Biophys. 2024 Sep;82(3):2427-2437. doi: 10.1007/s12013-024-01353-2. Epub 2024 Jun 15.
3
FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.成纤维细胞生长因子21缺失通过加剧心肌脂质积累而加重糖尿病心肌病。
J Cell Mol Med. 2015 Jul;19(7):1557-68. doi: 10.1111/jcmm.12530. Epub 2015 Mar 30.
4
Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes.细胞外 HSP60 通过激活和上调心肌细胞中的 TLRs 诱导炎症。
Cardiovasc Res. 2013 Jun 1;98(3):391-401. doi: 10.1093/cvr/cvt047. Epub 2013 Feb 27.
5
Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.成纤维细胞生长因子 21 通过 AMPK 介导的抗氧化和降脂作用预防糖尿病心肌病。
Cell Death Dis. 2018 Feb 14;9(2):227. doi: 10.1038/s41419-018-0307-5.
6
Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice.肠道形态和微生物群的明显改变可使非肥胖型糖尿病小鼠加速发病。
J Biol Chem. 2020 Jan 24;295(4):969-980. doi: 10.1074/jbc.RA119.010816. Epub 2019 Dec 10.
7
Overexpression of MD1 ameliorates pathological myocardial remodeling in diabetic cardiomyopathy by TLR4/STAT3 signaling pathway.过表达 MD1 通过 TLR4/STAT3 信号通路改善糖尿病心肌病病理性心肌重构。
Mol Cell Endocrinol. 2024 Oct 1;592:112315. doi: 10.1016/j.mce.2024.112315. Epub 2024 Jun 13.
8
Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder.生脉散通过改善线粒体脂质代谢紊乱减轻糖尿病心肌病
Cell Physiol Biochem. 2018;50(5):1726-1739. doi: 10.1159/000494791. Epub 2018 Nov 1.
9
Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.1 型糖尿病心肌病在 Akita(Ins2WT/C96Y)小鼠模型中表现为脂毒性和舒张功能障碍,收缩功能正常。
Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2096-108. doi: 10.1152/ajpheart.00452.2009. Epub 2009 Oct 2.
10
Adiponectin stimulates lipid metabolism via AMPK in rabbit blastocysts.脂联素通过 AMPK 刺激兔囊胚的脂质代谢。
Hum Reprod. 2017 Jul 1;32(7):1382-1392. doi: 10.1093/humrep/dex087.

引用本文的文献

1
Recent advances associated with cardiometabolic remodeling in diabetes-induced heart failure.糖尿病性心力衰竭中心血管代谢重构的最新进展。
Am J Physiol Heart Circ Physiol. 2024 Dec 1;327(6):H1327-H1342. doi: 10.1152/ajpheart.00539.2024. Epub 2024 Oct 25.
2
Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease.针对糖尿病性心脏病中巨噬细胞机制的治疗策略。
Cardiovasc Diabetol. 2024 May 15;23(1):169. doi: 10.1186/s12933-024-02273-4.
3
Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease.Toll样受体4(TLR4)与AMPK在心血管疾病中的相关性
Adv Pharm Bull. 2023 Jan;13(1):36-47. doi: 10.34172/apb.2023.004. Epub 2021 Oct 10.
4
Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: Inflammation and oxidative stress.葡萄糖和脂代谢紊乱与糖尿病心肌病的串扰特征:炎症和氧化应激。
Front Endocrinol (Lausanne). 2022 Sep 15;13:983713. doi: 10.3389/fendo.2022.983713. eCollection 2022.
5
Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy.糖尿病心肌病中与氧化应激相关的信号通路。
Front Endocrinol (Lausanne). 2022 Jun 15;13:907757. doi: 10.3389/fendo.2022.907757. eCollection 2022.
6
MD2 deficiency prevents high-fat diet-induced AMPK suppression and lipid accumulation through regulating TBK1 in non-alcoholic fatty liver disease.MD2 缺乏通过调节非酒精性脂肪肝病中的 TBK1 来防止高脂肪饮食诱导的 AMPK 抑制和脂质积累。
Clin Transl Med. 2022 Mar;12(3):e777. doi: 10.1002/ctm2.777.
7
Ca mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy.钙处理异常和线粒体功能障碍:通向糖尿病前期和糖尿病心肌病的共同道路。
Pflugers Arch. 2022 Jan;474(1):33-61. doi: 10.1007/s00424-021-02650-y. Epub 2022 Jan 3.
8
Protein overexpression of toll-like receptor 4 and myeloid differentiation factor 88 in oral squamous cell carcinoma and clinical significance.Toll样受体4和髓样分化因子88在口腔鳞状细胞癌中的蛋白过表达及临床意义
Oncol Lett. 2021 Nov;22(5):786. doi: 10.3892/ol.2021.13047. Epub 2021 Sep 14.
9
Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response.糖尿病心肌病通过炎症反应的机制及治疗前景
Front Physiol. 2021 Jun 21;12:694864. doi: 10.3389/fphys.2021.694864. eCollection 2021.
10
Application of Animal Models in Diabetic Cardiomyopathy.动物模型在糖尿病心肌病中的应用。
Diabetes Metab J. 2021 Mar;45(2):129-145. doi: 10.4093/dmj.2020.0285. Epub 2021 Mar 25.

本文引用的文献

1
Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling.Toll 样受体介导体炎性信号通过抑制过氧化物酶体增殖物激活受体 γ 共激活因子-1 信号转导来重新编程心脏能量代谢。
Circ Heart Fail. 2011 Jul;4(4):474-82. doi: 10.1161/CIRCHEARTFAILURE.110.959833. Epub 2011 May 10.
2
Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice.脂多糖诱导的促炎受体 TLR4 介导的胰岛素抵抗需要饱和脂肪酸诱导的鞘氨醇生物合成在小鼠中。
J Clin Invest. 2011 May;121(5):1858-70. doi: 10.1172/JCI43378. Epub 2011 Apr 1.
3
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.CD36 配体通过组装 Toll 样受体 4 和 6 异源二聚体促进无菌性炎症。
Nat Immunol. 2010 Feb;11(2):155-61. doi: 10.1038/ni.1836. Epub 2009 Dec 27.
4
Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion.心肌巨噬细胞移动抑制因子可抑制缺血/再灌注期间 JNK 通路的激活和损伤。
J Clin Invest. 2009 Dec;119(12):3807-16. doi: 10.1172/JCI39738. Epub 2009 Nov 16.
5
Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms.脂质供应过多、选择性胰岛素抵抗和脂毒性:分子机制
Biochim Biophys Acta. 2010 Mar;1801(3):252-65. doi: 10.1016/j.bbalip.2009.09.015. Epub 2009 Sep 29.
6
Rodent models of diabetic cardiomyopathy.糖尿病性心肌病的啮齿动物模型。
Dis Model Mech. 2009 Sep-Oct;2(9-10):454-66. doi: 10.1242/dmm.001941.
7
Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia.TLR4 信号转导缺陷可减轻缺血期间的心脏损伤和心肌细胞收缩功能障碍。
J Cell Mol Med. 2009 Aug;13(8A):1513-25. doi: 10.1111/j.1582-4934.2009.00798.x. Epub 2009 Jun 5.
8
Lipoprotein lipase: from gene to obesity.脂蛋白脂肪酶:从基因到肥胖
Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E271-88. doi: 10.1152/ajpendo.90920.2008. Epub 2009 Mar 24.
9
Innate immunity and intestinal microbiota in the development of Type 1 diabetes.1型糖尿病发病过程中的先天性免疫与肠道微生物群
Nature. 2008 Oct 23;455(7216):1109-13. doi: 10.1038/nature07336. Epub 2008 Sep 21.
10
Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.糖尿病性心肌病:对发病机制、诊断挑战及治疗选择的见解
Am J Med. 2008 Sep;121(9):748-57. doi: 10.1016/j.amjmed.2008.03.046.